rss
Br J Ophthalmol 2005;89:820-824 doi:10.1136/bjo.2004.060582
  • Clinical science
    • Scientific reports

Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene

  1. L Lauronen1,2,3,*,
  2. R Jalkanen4,*,
  3. J Huttunen1,3,
  4. E Carlsson4,
  5. S Tuupanen4,
  6. S Lindh5,
  7. H Forsius5,
  8. E-M Sankila5,6,
  9. T Alitalo4
  1. 1BioMag Laboratory, Helsinki University Central Hospital, Helsinki, Finland
  2. 2Helsinki Brain Research Centre, Helsinki, Finland
  3. 3Department of Clinical Neurophysiology, Helsinki University Central Hospital, Helsinki, Finland
  4. 4Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland
  5. 5The Folkhälsan Institute of Genetics, Department of Molecular Genetics, Helsinki, Finland
  6. 6Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
  1. Correspondence to: Tiina Alitalo Helsinki University Central Hospital, Department of OB/GYN, Genetics, Haartmaninkatu 2, PO Box 140, Helsinki, 00029 HUS, Finland; tiina.alitalohus.fi
  • Accepted 9 November 2004

Abstract

Aim: To perform genealogical and clinical studies in Finnish families with X linked ocular albinism (OA1), including characterisation of the potential misrouting of optic fibres by evaluating visual evoked magnetic fields (VEFs), and to determine the mutation behind the disease.

Methods: Three families with OA1 were clinically examined. VEFs were measured in two affected males and in one female carrier to characterise the cortical activation pattern after monocular visual stimulation. The neuronal sources of the VEFs were modelled with equivalent current dipoles (ECDs) in a spherical head model. All coding exons of the OA1 gene were screened for mutations by single strand conformation analysis and direct polymerase chain reaction sequencing.

Results: Genealogical studies revealed that the three families were all related. The affected males had foveal hypoplasia with reduced visual acuity varying from 20/200 to 20/50, variable nystagmus, iris transillumination, and hypopigmentation of the retinal pigment epithelium. The ECD locations corresponding to the VEFs revealed abnormal crossing of the optic fibres in both affected males, but not in the carrier female. A novel point mutation, leading to a STOP codon, was identified in the fifth exon of the OA1 gene.

Conclusions: The data indicate that the novel mutation 640C>T in the OA1 gene is the primary cause of the eye disease in the family studied. VEFs with ECD analysis was successfully used to demonstrate abnormal crossing of the optic fibres.

Footnotes

  • ↵* These authors contributed equally to this work.

  • Funding: This study was supported by the Helsinki University Hospital Grant, TYH1338 (TA), and the Finnish Eye Foundation (E-MS).

  • Competing interests: No commercial relationships for any authors.

  • Ethical approval: The study conformed to the tenets of the Declaration of Helsinki. Informed consent was obtained from all participants in accordance with the requirements of the Helsinki University Central Hospital, Department of Ophthalmology Ethics Committee.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.